Westside Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.89M | Sell |
22,902
-263
| -1% | -$34.7K | 0.38% | 67 |
|
|
2026
Q1 | $3.23M | Sell |
23,165
-349
| -1% | -$48.9K | 0.49% | 50 |
|
|
2025
Q4 | $2.88M | Sell |
23,514
-540
| -2% | -$65.6K | 0.46% | 57 |
|
|
2025
Q3 | $2.67M | Sell |
24,054
-532
| -2% | -$60.5K | 0.43% | 58 |
|
|
2025
Q2 | $2.73M | Buy |
24,586
+139
| +0.6% | +$14.8K | 0.51% | 53 |
|
|
2025
Q1 | $2.74M | Sell |
24,447
-2,898
| -11% | -$299K | 0.58% | 46 |
|
|
2024
Q4 | $2.53M | Sell |
27,345
-98
| -0.4% | -$8.82K | 0.53% | 50 |
|
|
2024
Q3 | $2.25M | Buy |
27,443
+917
| +3% | +$70K | 0.48% | 56 |
|
|
2024
Q2 | $1.83M | Buy |
26,526
+152
| +0.6% | +$10.1K | 0.42% | 62 |
|
|
2024
Q1 | $1.93M | Sell |
26,374
-897
| -3% | -$69K | 0.46% | 52 |
|
|
2023
Q4 | $2.21M | Sell |
27,271
-198
| -0.7% | -$15.4K | 0.56% | 48 |
|
|
2023
Q3 | $2.06M | Sell |
27,469
-868
| -3% | -$66.8K | 0.59% | 44 |
|
|
2023
Q2 | $2.18M | Sell |
28,337
-4,968
| -15% | -$396K | 0.62% | 40 |
|
|
2023
Q1 | $2.77M | Sell |
33,305
-3,140
| -9% | -$260K | 0.81% | 30 |
|
|
2022
Q4 | $733K | Sell |
36,445
-4,149
| -10% | -$329K | 1.81% | 8 |
|
|
2022
Q3 | $670K | Sell |
40,594
-1,767
| -4% | -$111K | 1.6% | 9 |
|
|
2022
Q2 | $667K | Sell |
42,361
-6,283
| -13% | -$389K | 1.51% | 12 |
|
|
2022
Q1 | $664K | Sell |
48,644
-1,340
| -3% | -$85.7K | 1.46% | 13 |
|
|
2021
Q4 | $786K | Sell |
49,984
-2,050
| -4% | -$141K | 1.79% | 7 |
|
|
2021
Q3 | $780K | Sell |
52,034
-2,000
| -4% | -$141K | 1.8% | 7 |
|
|
2021
Q2 | $767K | Sell |
54,034
-860
| -2% | -$57.4K | 1.78% | 10 |
|
|
2021
Q1 | $656K | Buy |
54,894
+7,822
| +17% | +$504K | 1.73% | 9 |
|
|
2020
Q4 | $637K | Buy |
47,072
+14,065
| +43% | +$849K | 1.75% | 8 |
|
|
2020
Q3 | $681K | Buy |
33,007
+7,495
| +29% | +$520K | 0.31% | 8 |
|
|
2020
Q2 | $590K | Sell |
25,512
-17,793
| -41% | -$1.36M | 0.35% | 6 |
|
|
2020
Q1 | $292K | Buy |
+43,305
| New | +$2.99M | 0.2% | 12 |
|
|
2019
Q2 | $228K | Buy |
+38,884
| New | +$2.56M | 0.5% | 6 |
|
|
2018
Q4 | $2.64M | Sell |
41,934
-574
| -1% | -$40.1K | 0.97% | 10 |
|
|
2018
Q3 | $3.29M | Sell |
42,508
-351
| -0.8% | -$26.5K | 1.05% | 9 |
|
|
2018
Q2 | $3.08M | Buy |
42,859
+3,686
| +9% | +$260K | 1.08% | 11 |
|
|
2018
Q1 | $2.87M | Sell |
39,173
-368
| -0.9% | -$29.3K | 1.57% | 11 |
|
|
2017
Q4 | $2.94M | Buy |
39,541
+2,820
| +8% | +$214K | 1.59% | 11 |
|
|
2017
Q3 | $3.01M | Sell |
36,721
-357
| -1% | -$27.3K | 1.82% | 10 |
|
|
2017
Q2 | $2.57M | Buy |
37,078
+666
| +2% | +$44.3K | 1.68% | 10 |
|
|
2017
Q1 | $2.42M | Buy |
36,412
+15,198
| +72% | +$1.07M | 1.16% | 10 |
|
|
2016
Q4 | $1.56M | Buy |
+21,214
| New | +$1.58M | 1.06% | 11 |
|
Other funds holding GILD
Westside Investment Management's GILD Position: Q2 2026 in Review
Westside Investment Management reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, selling an estimated $34.7K and leaving 22,902 shares worth $2.89M. The position accounts for 0.38% of the portfolio, ranked #67.
Westside Investment Management first reported a position in GILD in Q4 2016 and has held it in 36 quarters since. The position peaked at $3.29M in Q3 2018. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Westside Investment Management held 22,902 shares of Gilead Sciences worth $2.89M as of Q2 2026.
- Westside Investment Management sold 263 Gilead Sciences shares in Q2 2026, an estimated $34.7K.
- Gilead Sciences made up 0.38% of Westside Investment Management's portfolio in Q2 2026, its #67 holding.
- Westside Investment Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 36 quarters since.
- Westside Investment Management's Gilead Sciences position peaked at $3.29M in Q3 2018.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.